JCO:姑息治疗越早,节省越多

2015-06-13 MedSci MedSci原创

 姑息疗法现在已经被美国临床肿瘤学会(ASCO)推荐作为标准疗法,并且越来越多的用于重症疾病患者,带来了许多好处。姑息治疗可以减少治疗的花费,对病患的存活率和生活质量有好处。但是,目前鲜有证据表明更早的治疗是否有经济效益,即治疗时间的选择对于治疗花费有何影响? 研究人员收集了2007-2011年间美国5家医院的晚期癌症患者的临床和开支数据,利用这些数据进行前瞻性队列研究。样本共

姑息疗法现在已经被美国临床肿瘤学会(ASCO)推荐作为标准疗法,并且越来越多的用于重症疾病患者,带来了许多好处。姑息治疗可以减少治疗的花费,对病患的存活率和生活质量有好处。但是,目前鲜有证据表明更早的治疗是否有经济效益,即治疗时间的选择对于治疗花费有何影响?


研究人员收集了2007-2011年间美国5家医院的晚期癌症患者的临床和开支数据,利用这些数据进行前瞻性队列研究。样本共包含了969例晚期癌症患者;256人接受姑息治疗咨询团队的照看,其余713人只接受常规的治疗方案。根据送院治疗后咨询时间的不同还建立了附属样本。计算倾向权重评分以使得治疗和对照组与各个附属样板相配对。在附属样本组中使用广义线性模型估计治疗对开支的影响。相对于没有干预,在六天内进行干预开支估计可以减少1312美元,在两天之内进行干预可节省2280美元。这相当于分别节省了14%和24%的住院开支。

在住院后,更早的进行姑息治疗咨询可以减少罹患晚期癌症的病人的住院开支。这些研究成果和姑息治疗的其他好处是一致的。这表明及早进行姑息治疗应当被更广地推广和实施。这项研究将对姑息治疗的推广以及相关政策的制定实施产生重要的影响。

原始出处:

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1891196, encodeId=952f189119613, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Mon May 23 13:40:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29920, encodeId=80a02992068, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:48:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29375, encodeId=6e66293e58c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:40:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28045, encodeId=67a428045b5, content=也早放弃,花费越少, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28046, encodeId=9c6d2804636, content=不要期望有救命稻草, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27717, encodeId=5ca62e71770, content=看来姑息疗法也是有价值的, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19311619842, createdName=xcjick, createdTime=Mon Jun 15 23:26:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626615, encodeId=0e0816266153a, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Mon Jun 15 07:40:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
    2016-05-23 lidong40
  2. [GetPortalCommentsPageByObjectIdResponse(id=1891196, encodeId=952f189119613, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Mon May 23 13:40:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29920, encodeId=80a02992068, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:48:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29375, encodeId=6e66293e58c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:40:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28045, encodeId=67a428045b5, content=也早放弃,花费越少, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28046, encodeId=9c6d2804636, content=不要期望有救命稻草, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27717, encodeId=5ca62e71770, content=看来姑息疗法也是有价值的, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19311619842, createdName=xcjick, createdTime=Mon Jun 15 23:26:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626615, encodeId=0e0816266153a, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Mon Jun 15 07:40:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
    2015-06-29 owlhealth

    挺好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1891196, encodeId=952f189119613, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Mon May 23 13:40:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29920, encodeId=80a02992068, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:48:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29375, encodeId=6e66293e58c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:40:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28045, encodeId=67a428045b5, content=也早放弃,花费越少, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28046, encodeId=9c6d2804636, content=不要期望有救命稻草, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27717, encodeId=5ca62e71770, content=看来姑息疗法也是有价值的, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19311619842, createdName=xcjick, createdTime=Mon Jun 15 23:26:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626615, encodeId=0e0816266153a, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Mon Jun 15 07:40:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
    2015-06-25 huaxipanxing

    看看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1891196, encodeId=952f189119613, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Mon May 23 13:40:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29920, encodeId=80a02992068, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:48:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29375, encodeId=6e66293e58c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:40:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28045, encodeId=67a428045b5, content=也早放弃,花费越少, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28046, encodeId=9c6d2804636, content=不要期望有救命稻草, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27717, encodeId=5ca62e71770, content=看来姑息疗法也是有价值的, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19311619842, createdName=xcjick, createdTime=Mon Jun 15 23:26:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626615, encodeId=0e0816266153a, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Mon Jun 15 07:40:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
    2015-06-18 huangwukui

    也早放弃,花费越少

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1891196, encodeId=952f189119613, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Mon May 23 13:40:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29920, encodeId=80a02992068, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:48:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29375, encodeId=6e66293e58c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:40:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28045, encodeId=67a428045b5, content=也早放弃,花费越少, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28046, encodeId=9c6d2804636, content=不要期望有救命稻草, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27717, encodeId=5ca62e71770, content=看来姑息疗法也是有价值的, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19311619842, createdName=xcjick, createdTime=Mon Jun 15 23:26:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626615, encodeId=0e0816266153a, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Mon Jun 15 07:40:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
    2015-06-18 huangwukui

    不要期望有救命稻草

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1891196, encodeId=952f189119613, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Mon May 23 13:40:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29920, encodeId=80a02992068, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:48:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29375, encodeId=6e66293e58c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:40:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28045, encodeId=67a428045b5, content=也早放弃,花费越少, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28046, encodeId=9c6d2804636, content=不要期望有救命稻草, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27717, encodeId=5ca62e71770, content=看来姑息疗法也是有价值的, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19311619842, createdName=xcjick, createdTime=Mon Jun 15 23:26:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626615, encodeId=0e0816266153a, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Mon Jun 15 07:40:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]
    2015-06-15 xcjick

    看来姑息疗法也是有价值的

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1891196, encodeId=952f189119613, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Mon May 23 13:40:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29920, encodeId=80a02992068, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Mon Jun 29 18:48:00 CST 2015, time=2015-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=29375, encodeId=6e66293e58c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jun 25 23:40:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28045, encodeId=67a428045b5, content=也早放弃,花费越少, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28046, encodeId=9c6d2804636, content=不要期望有救命稻草, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Jun 18 09:01:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27717, encodeId=5ca62e71770, content=看来姑息疗法也是有价值的, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19311619842, createdName=xcjick, createdTime=Mon Jun 15 23:26:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626615, encodeId=0e0816266153a, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Mon Jun 15 07:40:00 CST 2015, time=2015-06-15, status=1, ipAttribution=)]

相关威廉亚洲官网

EPCRC发布首部癌症姑息治疗抑郁症管理威廉亚洲博彩公司

  癌症患者在姑息治疗中发生抑郁很常见,为使临床医师有“据”可依地进行处理,欧洲姑息治疗研究协作组(EPCRC)在系统性回顾了现有循证医学证据并进行了德尔斐(Delphi)研究后,制定出欧洲第一部癌症姑息治疗抑郁症管理威廉亚洲博彩公司 。相关内容参见《欧洲癌症杂志》 [Eur J Cancer 2011, 47(5): 702]。   姑息治疗中抑郁症的预

ONF:护士、护工在评估患者临床表现上存在差异

研究目的:目的是评估护士、护工和年老的姑息治疗的癌症患者对临床表现进行评定和评估的一致程度。设计方式:该研究为横断面研究。实验地点:实验在比利时法兰德斯的两所普通医院进行。样本:120名年龄大于等于65岁的采用姑息治疗的癌症患者。研究方式:williamhill asia 用一个经过审定的有36项指标的检测工具来评估老年罹患癌症并采用姑息治疗的患者的身体、心理、功能、社会、现存的临床表现,这些由病人、护士、护工独立完成。主要研

Gastrointest Endosc:近距离放射疗法生物可降解支架联合治疗增加吞咽困难并发症

    食管生物可降解支架置入术作为治疗吞咽困难的姑息疗法可立即改善症状,而近距离放射疗法提供了更好的长期治疗方案。来自荷兰的Meike Hirdes博士和同事们评估了采用近距离放射疗法和生物可降解支架置入术进行联合治疗的安全性和有效性。该文发表在2012年第76卷第2期《胃肠内窥镜检查(Gastrointestinal Endoscopy)》杂志上。       该团队评估了19例因无法切除的

加强对接受姑息治疗的癌症患者的护理

  英国研究人员称,晚期帕金森和其他运动障碍相关病人都有严重的身体和心理痛苦症状,这表明现这一阶段的护理还不够到位。英国伦敦国王学院Irene Higginson和PLoS ONE杂志的同事评论说,这些病人与癌症病人有类似的症状,这说明不是所有有姑息治疗需求的人都得到了相关护理。   他们报道,这一年的研究中,一半被研究对象的简要姑息治疗评估简表(POS)分值和症状上呈现上升

转移性非小细胞肺癌患者的早期姑息治疗

转移性非小细胞肺癌患者的早期姑息治疗 Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer  Jennifer S. Temel,等 美国波士顿市马萨诸塞总医院等 N Engl J Med 2010;363:733-42. August 19, 2010   背景 转移性非小细胞肺癌病人在